Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study

BACKGROUND: Genomic profiling of cerebrospinal fluid (CSF) can be used to detect actionable mutations and guide clinical treatment of non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastases. Examining the performance of CSF samples in real-world settings can confirm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Fangfang, Liang, Naixin, Fan, Zaiwen, Zhao, Min, Kang, Jing, Wang, Xifang, Hu, Qun, Mu, Yongping, Wang, Kai, Yuan, Mingming, Chen, Rongrong, Guo, Wei, Dong, Guilan, Zhao, Jun, Bai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259993/
https://www.ncbi.nlm.nih.gov/pubmed/35814426
http://dx.doi.org/10.3389/fonc.2022.889591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259993/
https://www.ncbi.nlm.nih.gov/pubmed/35814426
http://dx.doi.org/10.3389/fonc.2022.889591

Ejemplares similares